Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 33 Records) |
Query Trace: Carcinoma and ABCG2[original query] |
---|
Population analysis of erlotinib in adults and children reveals pharmacokinetic characteristics as the main factor explaining tolerance particularities in children. Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Jul 17 (14): 4862-71. White-Koning Melanie, Civade Elodie, Geoerger Birgit, Thomas Fabienne, Le Deley Marie-Cécile, Hennebelle Isabelle, Delord Jean-Pierre, Chatelut Etienne, Vassal Gill |
Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics. Drug metabolism and pharmacokinetics 2012 27 (6): 631-9. Mizuno Tomoyuki, Fukudo Masahide, Terada Tomohiro, Kamba Tomomi, Nakamura Eijiro, Ogawa Osamu, Inui Ken-Ichi, Katsura Toshi |
A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis. International journal of cancer. Journal international du cancer 2012 Dec 131 (12): 2920-8. Campa Daniele, Müller Phillip, Edler Lutz, Knoefel Lena, Barale Roberto, Heussel Claus P, Thomas Michael, Canzian Federico, Risch Ange |
Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients. Cancer chemotherapy and pharmacology 2013 Oct 72 (4): 825-35. Kim Hye Ryun, Park Hyung Soon, Kwon Woo Sun, Lee Ji Hyun, Tanigawara Yusuke, Lim Sun Min, Kim Hyo Song, Shin Sang Jun, Ahn Jung Bae, Rha Sun You |
The effect of ABCG2 genotype on the population pharmacokinetics of sunitinib in patients with renal cell carcinoma. Therapeutic drug monitoring 2014 Jun 36 (3): 310-6. Mizuno Tomoyuki, Fukudo Masahide, Fukuda Tsuyoshi, Terada Tomohiro, Dong Min, Kamba Tomomi, Yamasaki Toshinari, Ogawa Osamu, Katsura Toshiya, Inui Ken-Ichi, Vinks Alexander A, Matsubara Kaz |
Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer. Pharmacogenomics 2014 15 (12): 1565-74. Lamba Jatinder Kaur, Fridley Brooke L, Ghosh Taraswi M, Yu Qing, Mehta Gaurav, Gupta Pank |
Association of ABCB1 and FLT3 Polymorphisms with Toxicities and Survival in Asian Patients Receiving Sunitinib for Renal Cell Carcinoma. PloS one 2015 10 (8): e0134102. Chu Ying-Hsia, Li Huihua, Tan Hui Shan, Koh Valerie, Lai Johnathan, Phyo Wai Min, Choudhury Yukti, Kanesvaran Ravindran, Chau Noan Minh, Toh Chee Keong, Ng Quan Sing, Tan Puay Hoon, Chowbay Balram, Tan Min-H |
Genetic Variations in ABCG2 Gene Predict Breast Carcinoma Susceptibility and Clinical Outcomes after Treatment with Anthracycline-Based Chemotherapy. BioMed research international 2015 2015 279109. Wu Huizhe, Liu Yong, Kang Hui, Xiao Qinghuan, Yao Weifan, Zhao Haishan, Wang Enhua, Wei Minj |
Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy. Journal of experimental & clinical cancer research : CR 2015 34 2. Tecza Karolina, Pamula-Pilat Jolanta, Kolosza Zofia, Radlak Natalia, Grzybowska E |
Association of axitinib plasma exposure and genetic polymorphisms of ABC transporters with axitinib-induced toxicities in patients with renal cell carcinoma. Cancer chemotherapy and pharmacology 2016 Sep . Kato Hiroshi, Sassa Naoto, Miyazaki Masayuki, Takeuchi Mio, Asai Miho, Iwai Akane, Noda Yukihiro, Gotoh Momokazu, Yamada Kiyofu |
Clinical effects of single nucleotide polymorphisms on drug-related genes in Japanese metastatic renal cell carcinoma patients treated with sunitinib. Anti-cancer drugs 2016 Aug . Numakura Kazuyuki, Tsuchiya Norihiko, Kagaya Hideaki, Takahashi Makoto, Tsuruta Hiroshi, Inoue Takamitsu, Narita Shintaro, Huang Mingguo, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono |
Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction. PloS one 2016 11 (2): e0148177. Low Siew-Kee, Fukunaga Koya, Takahashi Atsushi, Matsuda Koichi, Hongo Fumiya, Nakanishi Hiroyuki, Kitamura Hiroshi, Inoue Takamitsu, Kato Yoichiro, Tomita Yoshihiko, Fukasawa Satoshi, Tanaka Tomoaki, Nishimura Kazuo, Uemura Hirotsugu, Hara Isao, Fujisawa Masato, Matsuyama Hideyasu, Hashine Katsuyoshi, Tatsugami Katsunori, Enokida Hideki, Kubo Michiaki, Miki Tsuneharu, Mushiroda Tais |
Association of Single Nucleotide Polymorphisms in STAT3, ABCB1, and ABCG2 with Stomatitis in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Analysis in Japanese Patients. Biological & pharmaceutical bulletin 2017 40 (4): 458-464. Watanabe Aimi, Yamamoto Kazuhiro, Ioroi Takeshi, Hirata Sachi, Harada Kenichi, Miyake Hideaki, Fujisawa Masato, Nakagawa Tsutomu, Yano Ikuko, Hirai Mido |
Characteristics of early-onset hematotoxicity of sunitinib in Japanese patients with renal cell carcinoma. BMC cancer 2017 Mar 17 (1): 214. Kato Renpei, Kato Yoichiro, Matsuura Tomohiko, Kanehira Mitsugu, Takata Ryo, Obara Wata |
Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study. Cancer chemotherapy and pharmacology 2017 Mar . Tandia Mahamadou, Mhiri Asma, Paule Bernard, Saffroy Raphaël, Cailliez Valérie, Noé Gaëlle, Farinotti Robert, Bonhomme-Faivre Lauren |
ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinib. Acta clinica Belgica 2018 May 1-9. Werbrouck Emilie, Bastin Julie, Lambrechts Diether, Verbiest Annelies, Van Brussel Thomas, Lerut Evelyne, Machiels Jean-Pascal, Verschaeve Vincent, Richard Vincent, Debruyne Philip R, Decallonne Brigitte, Schöffski Patrick, Bechter Oliver, Wolter Pascal, Beuselinck Beno |
Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma. Oncotarget 2018 Mar 9 (24): 17160-17170. Yamamoto Yoshiaki, Tsunedomi Ryouichi, Fujita Yusuke, Otori Toru, Ohba Mitsuyoshi, Kawai Yoshihisa, Hirata Hiroshi, Matsumoto Hiroaki, Haginaka Jun, Suzuki Shigeo, Dahiya Rajvir, Hamamoto Yoshihiko, Matsuyama Kenji, Hazama Shoichi, Nagano Hiroaki, Matsuyama Hideya |
Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma. Medical oncology (Northwood, London, England) 2018 Mar 35 (4): 51. Igarashi Ryoma, Inoue Takamitsu, Fujiyama Nobuhiro, Tsuchiya Norihiko, Numakura Kazuyuki, Kagaya Hideaki, Saito Mitsuru, Narita Shintaro, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono |
Rare Variants in the ABCG2 Promoter Modulate In Vivo Activity. Drug metabolism and disposition: the biological fate of chemicals 2018 2 46 (5): 636-642. Eclov Rachel J, Kim Mee J, Smith Robin, Ahituv Nadav, Kroetz Deanna |
ABCB1 3435TT and ABCG2 421CC genotypes were significantly associated with longer progression-free survival in Chinese breast cancer patients. Oncotarget 2017 Dec 8 (67): 111041-111052. Li Wanjun, Zhang Dan, Du Fen, Xing Xuemei, Wu Ying, Xiao Dong, Liang Ming, Fan Zhigang, Zhao Peng, Liu Tao, Li Guoy |
The contribution of ABCG2 G34A and C421A polymorphisms to multiple myeloma susceptibility. OncoTargets and therapy 2019 3 12 1655-1660. Niebudek Katarzyna, Balcerczak Ewa, Mirowski Marek, Pietrzak Jacek, Zawadzka Izabela, ?ebrowska-Nawrocka Mar |
Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients. Oral oncology 2019 Feb 89 72-78. Teft Wendy A, Winquist Eric, Nichols Anthony C, Kuruvilla Sara, Richter Suzanne, Parker Christina, Francis Peggy, Trinnear Maureen, Lukovic Jelena, Bukhari Nedal, Choi Yun-Hee, Welch Stephen, Palma David A, Yoo John, Kim Richard |
Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanoma. Pharmacogenomics 2019 12 20 (18): 1283-1290. Goey Andrew Kl, With Mirjam de, Agema Bram C, Hoop Esther Oomen-De, Singh Rajbir K, van der Veldt Astrid Am, Mathijssen Ron Hj, van Schaik Ron Hn, Bins Sand |
Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma. Frontiers in pharmacology 2021 3 12 641075. Sun Fengjun, Chen Zhuo, Yao Pu, Weng Bangbi, Liu Zhirui, Cheng L |
Polymorphism of FGD4 and myelosuppression in patients with esophageal squamous cell carcinoma. Future oncology (London, England) 2021 3 17 (18): 2351-2363. Yang Ying, Jia Jun, Sun Zhiwei, Liu Chuanling, Li Ziwei, Xiao Yanjie, Yu Jing, Du Feng, Shi Youwu, Sun Jing, Shui Jing, Zhang Xiaodo |
Impact of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of lenvatinib in patients with hepatocellular carcinoma. Journal of pharmacological sciences 2021 12 148 (1): 6-13. Okubo Hironao, Ando Hitoshi, Ishizuka Kei, Morishige Jun-Ichi, Ikejima Kenichi, Shiina Shuichiro, Nagahara Akihi |
Association between polymorphisms of ABCB1 and prognosis in esophageal squamous cell carcinoma patients treated with taxane. The journal of gene medicine 2022 Jun e3434. Sun Zhiwei, Yang Xin, Du Feng, Shi Youwu, Sun Jing, Jia Jun, Liu Chuanling, Xiao Yanjie, Yu Jing, Zhang Xiaodong, Yang Yi |
Child-Pugh Score and ABCG2-rs2231142 Genotype Independently Predict Survival in Advanced Hepatoma Patients Treated with Sorafenib. Journal of clinical medicine 2022 May 11 (9): . Huang Po-Han, Yu Jen, Chu Yin-Yi, Lin Yang-Hsiang, Yeh Chau-Ti |
Impact of ABCB1, ABCC1, ABCC2, and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum-based doublet chemotherapy. The journal of gene medicine 2022 10 25 (1): e3460. Sharma Parul, Singh Navneet, Sharma Siddhar |
Vitamin D receptor induces oxidative stress to promote esophageal squamous cell carcinoma proliferation via the p53 signaling pathway. Heliyon 2024 1 10 (1): e23832. Qi-Xin Shang, Yu-Shang Yang, Han-Lu Zhang, Ya-Ping Cheng, Han Lu, Yong Yuan, Long-Qi Chen, Ai-Fang |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: